FABBRONI, CHIARA
FABBRONI, CHIARA
Universita' degli Studi di MILANO
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
2020-01-01 G. Fucà, C. Fabbroni, R. Mancari, S. Manglaviti, G. Bogani, E. Fumagalli, R. Bertulli, C. Morosi, P. Collini, F. Raspagliesi, N. Colombo, P.G. Casali, R. Sanfilippo
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin
2021-03-01 C. Fabbroni, G. Fuca, F. Ligorio, E. Fumagalli, M. Barisella, P. Collini, C. Morosi, A. Gronchi, A.P.D. Tos, P.G. Casali, R. Sanfilippo
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
2019-07-01 C. Vernieri, M. Milano, M. Brambilla, A. Mennitto, C. Maggi, M.S. Cona, M. Prisciandaro, C. Fabbroni, L. Celio, G. Mariani, G.V. Bianchi, G. Capri, F. de Braud
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles
2019-04-01 C. Vernieri, M. Prisciandaro, M. Milano, M.S. Cona, C. Maggi, M. Brambilla, A. Mennitto, C. Fabbroni, E. Farè, S. Cresta, L. Celio, G. Mariani, G. Bianchi, G. Capri, F. de Braud